SNX9 antisense RNA 1 (SNX9-AS1)

**SNX9 antisense RNA 1** (SNX9-AS1) is a long non-coding RNA (lncRNA) transcribed from the genomic locus antisense to the SNX9 gene. Like other antisense lncRNAs, SNX9-AS1 is thought to regulate the expression of its sense gene partner—here, sorting nexin 9 (SNX9)—by various epigenetic, transcriptional, or post-transcriptional mechanisms such as recruiting chromatin-modifying enzymes or forming RNA duplexes with the sense mRNA[1][4][6]. While some antisense lncRNAs are directly implicated in cancer, cell proliferation, or other critical signaling pathways, there is no specific experimental evidence in the available literature indicating that SNX9-AS1 itself serves as a therapeutic target, cancer biomarker, or regulator of human disease as of this writing. Thus, SNX9-AS1 is best classified as an antisense lncRNA of potential regulatory importance, but not as a direct therapeutic target or receptor[1][4][6]. Key context: - Sorting nexin 9 (SNX9), the sense gene to SNX9-AS1, is a protein involved in membrane trafficking, endocytosis, and actin remodeling[2][5][7][8]. - Antisense lncRNAs as a class are of research interest for their regulatory functions, but their roles must be established experimentally for each specific transcript[1][4][6]. - No drugs, biomarkers, or specific mechanisms of therapeutic modulation are linked to SNX9-AS1 specifically in the available literature[1][4][6].

Other names

SNX9-AS1